10. Galenus Workshop (11.bis 13. September 2024)

Unter dem Titel „Exploring the Future of Inhalation Drug Delivery“ organisiert Frau Prof. Francesca Buttini vom Food and Drug Department der Universität Parma (Italien) einen dreitägigen Galenus Workshop in Parma. Details zum Programm der Veranstaltung, die in englischer Sprache stattfindet, werden in Kürze veröffentlicht.

Programm

WEDNESDAY, September 11
SPEAKERTITLETIME
Francesca Buttini
(University of Parma)
Cornelia Désirée Sonntag
(Galenus Foundation)
Conference opening9:00-9:10

NEW PARADIGMS IN LUNG DELIVERY

David Edwards
(Harvard University, US)
Chronic cough, airway rehydration, and
climate change
9:10-9:40
Michael Hindle
(Virginia Commonwealth
University, US)
Development of a lung surfactant powder
aerosol product for babies with respiratory
distress syndrome
9:40-10:05
Pavan Muttil
(University of New
Mexico, US)
Formulation development and preclinical
evaluation of aerosol vaccines: challenges, opportunities and lessons learnt
10:05-10:30
 To be selected from abstracts submitted10:30-10:45
COFFEE BREAK + POSTER SESSION
Nicola Tsapis
(Paris-Saclay University, France)
Nanomedicines and microparticles for the
treatment of pulmonary infections
11:25-11:50
David Cipolla (Insmed, USA)Preclinical and CMC development of
treprostinil palmitil inhalation powder
11:50-12:15
Paul Hagedoorn
(University of Groningen,
The Netherlands)
The development of pulmonary levodopa
applications for patients with Parkinson’s
disease
12:15-12:40
LIGHT LUNCH + POSTER SESSION

RESPIRATORY TREE AS A SITE FOR THE DELIVERY OF BIOLOGICS

Tomaso Guidi
(Chiesi, Italy)
Inhaled biologics: current trends in the
industry
14:20-14:40
Francesca Buttini
(University of Parma, Italy)
The formulation of protein and probiotics in
dry powder inhalers
14:40-15:05
 To be selected from abstracts submitted15:05-15:20
 To be selected from abstracts submitted15:20-15:35
COFFEE BREAK + POSTER SESSION
Regina Scherließ
(Kiel University, Germany)
Nasal vaccine technology16:15-16:40
Ben Forbes
(King’s College, UK)
Biologics from nose to brain16:40-17:05
 To be selected from the abstract submitted17:05-17:20
WELCOME RECEPTION

 

THURSDAY, September 12
SPEAKERTITLETIME

BIOLOGICS LOVE LUNGS

Hugh Smyth
(University of Texas at
Austin, US)
Developing inhaled mAbs and nucleic acids
for therapeutic success
9:00-9:30
Jenny Lam
(University of Central
London, UK)
How to make antibodies formulation stable
and inhalable
9:30-9:55
 To be selected from abstracts submitted9:55-10:10
 To be selected from abstracts submitted10:10-10:25
COFFEE BREAK + POSTER SESSION

ENVIRONMENTAL PROTECTION BECOMES A REALITY IN THE DEVELOPMENT OF PMDI

Barzin Gavtash and
Benjamin Myatt
(Kindeva, UK)
Atomization properties and aerosol
characteristics of new low GWP propellants
11:05-11:30
TBA
(Chiesi, Italy)
Re-formulation of pMDI in HFA152a11:30-11:55
David Lecthuga
(Astra Zeneca, US)
pMDI: stable suspension in HFO1234ze11:55-12:20
TBA
RxPack (Italy)
Re-formulation of beclomethasone
diproprionate ethanol-based solution in new eco-sustainable propellants
12:20-12:35
LIGHT LUNCH + POSTER SESSION

LAST FRONTIERS IN LUNG INFECTION

Keertan Dheda
(University of Cape Town,
South Africa)
Challenges in the prevention and
management of drug-sensitive and drugresistant
TB
14:20-14:45
Lea Ann Daily
(University of Vienna, Austria)
A liposomal strategy for inhaled bedaquiline: in vivo pharmacodynamics and pharmacokinetics14:45-15:10
Francesca Ungaro
(University of Naples, Italy)
Novel formulation approaches for lung
infection treatment
15:10-15:35
Mirjam Kobler
(H&T Presspart, UK)
The sunriser – achieving high performance
in challenging formulations
15:35-15:50
COFFEE BREAK + POSTER SESSION
PhD Students Contest Seven7thSeven talks of 7 minutes selected from abstract submission16:20-17:20
GALA DINNER

 

FRIDAY, September 13
SPEAKERTITLETIME

NEW RESEARCH

Federico Lavorini
(University of Florence, Italy)
Physiological and technological barriers in
the treatment of COPD
9:00-9:30
Jan de Backer
(FLUIDDA, USA)
The role of digital twins and in-silico trials
as regulatory tools for the authorization of
orally inhaled drugs
9:30-9:55
Carsten Ehrhardt
(Trinity College, Ireland)
Uptake mechanisms of molecules released
into the lungs
9:55-10:20
COFFEE BREAK + POSTER SESSION
Daniela Traini
(Macquarie University, Australia)
Non-clinical tests in the evaluation of
inhaled pharmaceuticals
11:00-11:25
Per Backmann
(Emmace, Sweden)
Physiologically-based biopharmaceutical
models- a tool to understand local and
systemic exposure of inhaled medicines
11:25-11:50
Amrit Paudel
(RCPE, Austria)
Empowering drug-drug co-amorphous
inhaled formulation design using datadriven approach
11:50-12:15
CLOSING REMARKS